{"schema_version":"secwatch.filing_event.v1","accession":"0001159036-25-000036","form_type":"8-K","ticker":"HALO","cik":"0001159036","company_name":"HALOZYME THERAPEUTICS, INC.","filed_at":"2025-10-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.904100+00:00","generated_at":"2026-05-17T04:32:55.183715+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Halozyme appoints Cortney Caudill as COO; base salary $600K, equity award $500K","bullets":["Cortney Caudill appointed SVP, COO effective Oct 1, 2025; previously SVP, Chief Operations Officer since Oct 2023.","Annual base salary set at $600,000; eligible for executive incentive plans with 2025 bonus target of 50% of salary.","Receives $500K equity award (50% stock options, 50% RSUs) vesting over four years.","No family relationships or material interests in any transactions with the Company."],"urls":{"canonical":"https://secwatch.observer/filing/0001159036-25-000036","json":"https://secwatch.observer/filing/0001159036-25-000036.json","markdown":"https://secwatch.observer/filing/0001159036-25-000036.md","text":"https://secwatch.observer/filing/0001159036-25-000036.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1159036/000115903625000036/0001159036-25-000036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1159036/000115903625000036/halo-20251001.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:32:55.183715+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}